Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Gsa Capital Partners LLP

SEC CIK
0001362033
Latest filing
Aug 6, 2026

The latest 13F from Gsa Capital Partners LLP covers Q2 2026 (filed Aug 6, 2026): 1,692 long positions worth $1.59B. The top 10 holdings make up 7.3% of the portfolio, and the largest is Vanguard Scottsdale FDS at 2.3%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Full comparison

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

New
605
Est. +$394.2M
Added
524
Est. +$305.0M
Reduced
558
Est. −$476.4M
Sold out
577
Est. −$422.4M

Top 5 holdings

Share of this quarter's portfolio value

  1. Vanguard Scottsdale FDS92206C409
    2.3%$36.1M
  2. iShares Tr464288646
    1.0%$16.4M
  3. Vanguard Intermediate-Term Corporate Bond ETF92206C870
    0.8%$12.2M
  4. State Street SPDR Portfolio Short Term Corporate Bond ETF78464A474
    0.6%$9.37M
  5. iShares Tr46429B655
    0.6%$8.94M

Share of portfolio

Top 5 holdings and the other 1,687 positions, by share of portfolio value

  1. Vanguard Scottsdale FDS2.3%
  2. iShares Tr1.0%
  3. Vanguard Intermediate-Term Corporate Bond ETF0.8%
  4. State Street SPDR Portfolio Short Term Corporate Bond ETF0.6%
  5. iShares Tr0.6%
  6. Other 1,687 positions94.8%

Biggest buys

New and added positions, by estimated amount bought

  1. TJXTJX Companies Inc
    +$5.42MAddedHistory
  2. NOCNorthrop Grumman Corp
    +$5.25MNewHistory
  3. MDTMedtronic plc
    +$4.92MAddedHistory
  4. JHGJanus Henderson Group Ltd.
    +$4.88MAddedHistory
  5. PGProcter & Gamble Co
    +$4.41MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. TJXTJX Companies Inc
    +0.34 pp<0.1% → 0.4%History
  2. NOCNorthrop Grumman Corp
    +0.33 pp0.0% → 0.3%History
  3. JHGJanus Henderson Group Ltd.
    +0.31 pp<0.1% → 0.3%History
  4. MDTMedtronic plc
    +0.31 pp<0.1% → 0.3%History
  5. PGProcter & Gamble Co
    +0.28 pp0.0% → 0.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. iShares Iboxx $ Investment Grade Corporate Bond ETF464287242
    −$28.0MSold out
  2. iShares Tr464288513
    −$22.8MSold out
  3. Vanguard Intermediate-Term Corporate Bond ETF92206C870
    −$20.0MReduced
  4. SPDR Series Trust78468R622
    −$12.5MReduced
  5. Vanguard Scottsdale FDS92206C409
    −$8.13MReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. iShares Iboxx $ Investment Grade Corporate Bond ETF464287242
    −1.74 pp1.7% → 0.0%
  2. iShares Tr464288513
    −1.42 pp1.4% → 0.0%
  3. Vanguard Intermediate-Term Corporate Bond ETF92206C870
    −1.24 pp2.0% → 0.8%
  4. SPDR Series Trust78468R622
    −0.77 pp0.8% → <0.1%
  5. Vanguard Scottsdale FDS92206C409
    −0.48 pp2.8% → 2.3%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.59B
−$22.5M (−1.4%) vs. prior quarter
Positions
1,692
+28 vs. prior quarter
Top 10 concentration
7.3%
Top 10 as share of value
Turnover
43.8%
Q2 2026, one quarter
Average holding period
3.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.61B (Q1 2026)

Q1 2021: $602.7MQ2 2021: $888.7MQ3 2021: $981.6MQ4 2021: $796.1MQ1 2022: $745.0MQ2 2022: $666.3MQ3 2022: $753.9MQ4 2022: $805.5MQ1 2023: $1.01BQ2 2023: $1.00BQ3 2023: $1.17BQ4 2023: $1.19BQ1 2024: $1.26BQ2 2024: $1.43BQ3 2024: $1.32BQ4 2024: $1.35BQ1 2025: $1.11BQ2 2025: $1.43BQ3 2025: $1.20BQ4 2025: $1.16BQ1 2026: $1.61BQ2 2026: $1.59B
Q1 2021Q2 2026
13F filings of Gsa Capital Partners LLP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 6, 20261,692$1.59BVanguard Scottsdale FDSiShares TrVanguard Intermediate-Term Corporate Bond ETFvs. Q1 2026SEC
Q1 2026May 8, 20261,664$1.61BVanguard Scottsdale FDSVanguard Intermediate-Term Corporate Bond ETFiShares Iboxx $ Investment Grade Corporate Bond ETFvs. Q4 2025SEC
Q4 2025Feb 6, 20261,617$1.16BiShares TrNVDARELYvs. Q3 2025SEC
Q3 2025Nov 7, 20251,596$1.20BACNSFMMSFTvs. Q2 2025SEC
Q2 2025Jul 22, 20251,695$1.43BNVDAMSFTAAPLvs. Q1 2025SEC
Q1 2025May 8, 20251,596$1.11BGOOGLPGRCSXvs. Q4 2024SEC
Q4 2024Feb 7, 20251,558$1.35BiShares Core S&P 500 ETFAMZNMSFTvs. Q3 2024SEC
Q3 2024Nov 5, 20241,537$1.32BNVDAMSFTGOOGLvs. Q2 2024SEC
Q2 2024Aug 15, 20241,577$1.43BDVNVITLFISVvs. Q1 2024SEC
Q1 2024May 3, 20241,554$1.26BPGRAMZNROOTvs. Q4 2023SEC
Q4 2023Feb 16, 20241,434$1.19BAMZNCRHRELYvs. Q3 2023SEC
Q3 2023Nov 15, 20231,437$1.17BNVDATECKADBEvs. Q2 2023SEC
Q2 2023Aug 14, 20231,456$1.00BELFWENNEvs. Q1 2023SEC
Q1 2023May 12, 20231,430$1.01BiShares TrHLTATVIvs. Q4 2022SEC
Q4 2022Feb 13, 20231,396$805.5MPCGiShares TrRIGvs. Q3 2022SEC
Q3 2022Nov 14, 20221,460$753.9MSBUXGOJACKvs. Q2 2022SEC
Q2 2022Aug 9, 20221,338$666.3MGRLAYiShares Trvs. Q1 2022SEC
Q1 2022May 11, 20221,357$745.0MAMZNTMXCHSvs. Q4 2021SEC
Q4 2021Feb 14, 20221,361$796.1MLBTYAState Street Consumer Staples Select Sector SPDR ETFState Street SPDR S&P Regional Banking ETFvs. Q3 2021SEC
Q3 2021Nov 12, 20211,364$981.6MMSMETAMSFTvs. Q2 2021SEC
Q2 2021Aug 5, 20211,283$888.7MAMZNAAPLMETAvs. Q1 2021SEC
Q1 2021May 10, 20211,049$602.7MBIDUFarfetch LtdVIPS–SEC

13D and 13G filings

Companies where Gsa Capital Partners LLP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Gsa Capital Partners LLP does not currently report owning 5% or more of any company.

Latest filings

4 filings on file made by Gsa Capital Partners LLP or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Gsa Capital Partners LLP
CompanyFiled (ET)FormStakeChangeEvent dateFiling
GRTXGalera Therapeutics, Inc.Jan 2, 202413GOld format–New–SEC
TTOOT2 Biosystems, Inc.Jul 31, 202313GOld format–––SEC
TTOOT2 Biosystems, Inc.Jun 30, 202313GOld format–––SEC
TTOOT2 Biosystems, Inc.Jun 21, 202313GOld format–New–SEC